Clinical Trial Update: A Pivotal Study of APG-2575 (Lisaftoclax) Combined With Azacitidine in the Treatment of Acute Myeloid Leukemia [Phase 3]

View source ↗

Summary

Update on a Phase 3 pivotal trial evaluating APG-2575 (Lisaftoclax) in combination with Azacitidine for acute myeloid leukemia; the study is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• APG-2575 (Lisaftoclax) (Lisaftoclax)
• AZACITIDINE (AZACITIDINE)

Snippet

Sponsor: Ascentage Pharma Group Inc. | Conditions: Acute Myeloid Leukemia | Phase 3 | Status: RECRUITING